The FDA granted approval on December 22, 2025, making the Wegovy Pill the first oral GLP-1 specifically indicated for weight loss
This piece walks through what the Ro weight-loss program actually involves: the intake, the provider model, the medication choices, the cost drivers, and the one upstream factor the program does not measure
Who Should Avoid Retatrutide or Use It With Caution People with severe gastroparesis, a history of pancreatitis, gallbladder disease, pregnancy, or those taking insulin or narrow-therapeutic-index oral medicines should avoid or use retatrutide with particular caution
These injections are becoming increasingly popular as an alternative to surgical procedures such as liposuction
It makes patients feel full sooner and increases the release of insulin from the pancreas to control blood sugar, she said
This move could dramatically expand access to Eli Lilly's Foundayo and Zepbound and Novo Nordisk's Wegovy for seniors 65 and older as well as other eligible Medicare enrollees